A carregar...
Phase I/II Trial of Clofarabine and Cytarabine in Children With Relapsed/Refractory Acute Lymphoblastic Leukemia (AAML0523): A Report From the Children’s Oncology Group
BACKGROUND: The discovery of effective re-induction regimens for children with more than one relapse of acute lymphoblastic leukemia (ALL) remains elusive. The novel nucleoside analog clofarabine exhibits modest single agent efficacy in relapsed ALL, though optimal combinations of this agent with ot...
Na minha lista:
| Publicado no: | Pediatr Blood Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4605828/ https://ncbi.nlm.nih.gov/pubmed/23335239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24398 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|